Prof. Dr. Shiv Singh
Shiv Singh is a Principal Investigator of SP2 and a member of the Selection Comittee.
His research focus lies on epigenetic and transcriptional networks in Pancreatic Ductal Adenocarcinoma (PDAC) heterogeneity and therapy response.
Professor Singh is a faculty and advisory committee member of the International Max Planck Research School for Genome Science graduate school (IMPRS-GS), PI in the Clinician Scientist Program “Cell Dynamics in pathogenesis and therapy” at the UMG Promotionskolleg for MD students, and a faculty and examination committee member of the University of Göttingen graduate Schools (GGNB, GAUSS, DNB and UMG). In addition, he teaches Cancer Biology to M.Sc. students (DNB program), and Bionmedical Sciences to MD students.
Curriculum Vitae
| Year | Position |
| Since 2025 | Since 2025: Mildred-Scheel Professor, University Professor and Chair, Targeting Tumor Heterogeneity, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG |
| 2022-2025 | Tenure Extension of Max-Eder Group Leader position, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG |
| 2018-2022 | Max-Eder Group Leader, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG |
| 2016-2018 | Junior Group Leader, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG, Germany |
| 2014-2016 | Postdoctoral Fellow, Barrow Neurological Institute, Phoenix, AZ, USA |
| 2011-2013 | Postdoctoral Fellow, Philipps University Marburg, Germany |
| 2006-2010 | Dr. rer. physiol (summa cum laude), Philipps-University of Marburg, Germany |